OBJECTIVES: To measure the prevalence and to identify risk factors of hearing impairment in human immunodeficiency virus-infected children living in Peru. STUDY DESIGN: Cross-sectional observational study. SETTING: Two public hospitals and 1 nonprofit center in Lima, Peru, between August 2009 and April 2010. SUBJECTS: A total of 139 HIV-infected children, ages 4 to 19 years. METHODS: Hearing impairment and otologic health were assessed with pure tone audiometry, tympanometry, and otoscopy. The primary outcome was hearing loss, defined as average threshold >25dB for 0.5, 1, 2, and 4 kHz, in one or both ears. Historical and socioeconomic information was obtained through parental survey and medical chart review. Statistical analysis included univariate analysis and multivariate logistic regression. RESULTS: Fifty-four (38.8%) of 139 children had hearing impairment. On multivariate analysis, risk factors included: tympanic membrane perforation (odds ratio [OR] 7.08; 95% confidence interval [CI], 1.65-30.5; P = .01), abnormal tympanometry (OR 2.71; 95% CI, 1.09-6.75; P = .03), cerebral infection (OR 11.6; 95% CI, 1.06-126; P = .05), seizures (OR 5.20; 95% CI, 1.21-22.4; P = .03), and CD4 cell count <500 cells/mm(3) (OR 3.53; 95% CI, 1.18-10.5; P = .02). CONCLUSIONS: The prevalence of hearing impairment in HIV-infected children in Lima, Peru was 38.8%. Middle ear disease, prior cerebral infection, and low CD4 cell count were significantly associated with hearing impairment. The high prevalence of hearing impairment emphasizes the need for periodic hearing assessment in the routine clinical care of HIV-infected children.
OBJECTIVES: To measure the prevalence and to identify risk factors of hearing impairment in human immunodeficiency virus-infectedchildren living in Peru. STUDY DESIGN: Cross-sectional observational study. SETTING: Two public hospitals and 1 nonprofit center in Lima, Peru, between August 2009 and April 2010. SUBJECTS: A total of 139 HIV-infectedchildren, ages 4 to 19 years. METHODS:Hearing impairment and otologic health were assessed with pure tone audiometry, tympanometry, and otoscopy. The primary outcome was hearing loss, defined as average threshold >25dB for 0.5, 1, 2, and 4 kHz, in one or both ears. Historical and socioeconomic information was obtained through parental survey and medical chart review. Statistical analysis included univariate analysis and multivariate logistic regression. RESULTS: Fifty-four (38.8%) of 139 children had hearing impairment. On multivariate analysis, risk factors included: tympanic membrane perforation (odds ratio [OR] 7.08; 95% confidence interval [CI], 1.65-30.5; P = .01), abnormal tympanometry (OR 2.71; 95% CI, 1.09-6.75; P = .03), cerebral infection (OR 11.6; 95% CI, 1.06-126; P = .05), seizures (OR 5.20; 95% CI, 1.21-22.4; P = .03), and CD4 cell count <500 cells/mm(3) (OR 3.53; 95% CI, 1.18-10.5; P = .02). CONCLUSIONS: The prevalence of hearing impairment in HIV-infectedchildren in Lima, Peru was 38.8%. Middle ear disease, prior cerebral infection, and low CD4 cell count were significantly associated with hearing impairment. The high prevalence of hearing impairment emphasizes the need for periodic hearing assessment in the routine clinical care of HIV-infectedchildren.
Authors: Josephine A Czechowicz; Anna H Messner; Edith Alarcon-Matutti; Jorge Alarcon; Gina Quinones-Calderon; Silvia Montano; Joseph R Zunt Journal: Otolaryngol Head Neck Surg Date: 2010-02 Impact factor: 3.497
Authors: Anni Taipale; Tuula Pelkonen; Marko Taipale; Irmeli Roine; Luis Bernardino; Heikki Peltola; Anne Pitkäranta Journal: Eur Arch Otorhinolaryngol Date: 2011-03-25 Impact factor: 2.503
Authors: Sarah K Himes; Yanling Huo; George K Siberry; Paige L Williams; Mabel L Rice; Patricia A Sirois; Toni Frederick; Rohan Hazra; Marilyn A Huestis Journal: J Acquir Immune Defic Syndr Date: 2015-06-01 Impact factor: 3.731
Authors: Peter Torre; Jonathan S Russell; Renee Smith; Howard J Hoffman; Sonia Lee; Paige L Williams; Tzy-Jyun Yao Journal: Am J Audiol Date: 2020-01-31 Impact factor: 1.493
Authors: Ayotunde James Fasunla; Babatunde Oluwatosin Ogunbosi; Georgina Njideka Odaibo; Onyekwere George Benjamin Nwaorgu; Babafemi Taiwo; David Olufemi Olaleye; Kikelomo Osinusi; Robert Leo Murphy; Isaac Folorunso Adewole; Olusegun Olusina Akinyinka Journal: AIDS Date: 2014-09-24 Impact factor: 4.177
Authors: Peter Torre; Bret Zeldow; Howard J Hoffman; Ashley Buchanan; George K Siberry; Mabel Rice; Patricia A Sirois; Paige L Williams Journal: Pediatr Infect Dis J Date: 2012-08 Impact factor: 2.129
Authors: Doreen Nakku; Victoria Nyaiteera; Evelyn Llowet; Dennis Nanseera; Gladys Nakalema; Brian Westerberg; Francis Bajunirwe Journal: Int J Pediatr Otorhinolaryngol Date: 2017-08-14 Impact factor: 1.675
Authors: Travis White-Schwoch; Albert K Magohe; Abigail M Fellows; Catherine C Rieke; Brandon Vilarello; Trent Nicol; Enica R Massawe; Ndeserua Moshi; Nina Kraus; Jay C Buckey Journal: Clin Neurophysiol Date: 2020-05-22 Impact factor: 3.708
Authors: Susan Hrapcak; Hannah Kuper; Peter Bartlett; Akash Devendra; Atupele Makawa; Maria Kim; Peter Kazembe; Saeed Ahmed Journal: PLoS One Date: 2016-08-23 Impact factor: 3.240